Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2013 - 2026)

Phibro Animal Health has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 10.31% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $5.7 billion, a 16.38% increase from a year earlier, with the FY2026 full-year figure at $1.5 billion, up 10.31% from the prior year.
• Liabilities and Shareholders Equity was $1.5 billion for Q2 2026 at Phibro Animal Health, up from $1.4 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $1.5 billion in Q2 2026, with the low at $916.2 million in Q1 2022.
• Average Liabilities and Shareholders Equity over 5 years is $1.1 billion, with a median of $975.9 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity rose 0.18% in 2024, then jumped 43.39% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $961.8 million in 2022, then climbed by 1.13% to $972.7 million in 2023, then jumped by 32.16% to $1.3 billion in 2024, then advanced by 9.34% to $1.4 billion in 2025, then climbed by 6.81% to $1.5 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.5 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.